PMID- 25818429 OWN - NLM STAT- MEDLINE DCOM- 20151231 LR - 20150330 IS - 1878-5905 (Electronic) IS - 0142-9612 (Linking) VI - 52 DP - 2015 Jun TI - Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles. PG - 229-39 LID - S0142-9612(15)00162-3 [pii] LID - 10.1016/j.biomaterials.2015.02.044 [doi] AB - To evaluate the effects of mannose density on in vitro and in vivo cellular uptake and RNA interference (RNAi) efficiency of polymeric nanoparticles (NPs) in macrophages, mannose-modified trimethyl chitosan-cysteine (MTC) conjugates with mannose densities of 4%, 13%, and 21% (MTC-4, MTC-13, and MTC-21) were synthesized. Tumor necrosis factor-alpha (TNF-alpha) siRNA loaded MTC NPs with particle sizes of approximately 150 nm exhibited desired structural stability and effectively protected siRNA from enzymatic degradation. Generally, cellular uptake and RNAi efficiency were affected by mannose density. As expected, MTC-21 NPs presented the maximum in vitro uptake and RNAi efficacy in Raw 264.7 cells among all NPs tested. However, MTC-4 NPs exhibited the optimal in vivo uptake by peritoneal exudate cell macrophages (PECs). In the inflammation model of acute hepatic injury, orally delivered MTC-4 and MTC-13 NPs worked better in silencing TNF-alpha expression and alleviating liver damage than MTC-21 NPs. As for the ulcerative colitis model, MTC-4 NPs outperformed MTC-13 and MTC-21 NPs with respect to TNF-alpha knockdown and therapeutic efficacy following oral administration. These results highlighted the importance of ligand density in cellular uptake and RNAi efficiency, which could serve as a guideline in the rational design of targeted nanocarriers for anti-inflammation therapy. CI - Copyright (c) 2015 Elsevier Ltd. All rights reserved. FAU - Chu, Shuang AU - Chu S AD - State Key Laboratory of Genetic Engineering, Department of Pharmaceutical Sciences, School of Life Sciences, Fudan University, Shanghai 200433, China. FAU - Tang, Cui AU - Tang C AD - State Key Laboratory of Genetic Engineering, Department of Pharmaceutical Sciences, School of Life Sciences, Fudan University, Shanghai 200433, China. Electronic address: tangcui@fudan.edu.cn. FAU - Yin, Chunhua AU - Yin C AD - State Key Laboratory of Genetic Engineering, Department of Pharmaceutical Sciences, School of Life Sciences, Fudan University, Shanghai 200433, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150227 PL - Netherlands TA - Biomaterials JT - Biomaterials JID - 8100316 RN - 0 (Drug Carriers) RN - 0 (Ligands) RN - 0 (Polymers) RN - 0 (RNA, Small Interfering) RN - 0 (Tumor Necrosis Factor-alpha) RN - 9012-76-4 (Chitosan) RN - K848JZ4886 (Cysteine) RN - PHA4727WTP (Mannose) SB - IM MH - Administration, Oral MH - Animals MH - Cell Line MH - Chitosan/chemistry MH - Cysteine/chemistry MH - Drug Carriers/chemistry MH - Inflammation/metabolism MH - Ligands MH - Liver/metabolism/pathology MH - Macrophages, Peritoneal/*metabolism MH - Male MH - Mannose/*chemistry MH - Mice MH - Mice, Inbred C57BL MH - Nanoparticles/*chemistry MH - Particle Size MH - Polymers/*chemistry MH - RAW 264.7 Cells MH - *RNA Interference MH - RNA, Small Interfering/metabolism MH - Tumor Necrosis Factor-alpha/administration & dosage/chemistry OTO - NOTNLM OT - Cellular uptake OT - Gene delivery OT - Gene silencing OT - Mannose density OT - Polymeric nanoparticles EDAT- 2015/03/31 06:00 MHDA- 2016/01/01 06:00 CRDT- 2015/03/31 06:00 PHST- 2014/09/19 00:00 [received] PHST- 2015/02/05 00:00 [revised] PHST- 2015/02/06 00:00 [accepted] PHST- 2015/03/31 06:00 [entrez] PHST- 2015/03/31 06:00 [pubmed] PHST- 2016/01/01 06:00 [medline] AID - S0142-9612(15)00162-3 [pii] AID - 10.1016/j.biomaterials.2015.02.044 [doi] PST - ppublish SO - Biomaterials. 2015 Jun;52:229-39. doi: 10.1016/j.biomaterials.2015.02.044. Epub 2015 Feb 27.